Medicare Enrolled
Dr. Mohamed Khalil, M.D.
Sports Medicine (Neuromusculoskeletal Medicine) Physician · Webster, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Khalil from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khalil? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Khalil
Dr. Mohamed Khalil is a sports medicine (neuromusculoskeletal medicine) physician in Webster, TX, with 14 years in practice. Based on federal Medicare data, Dr. Khalil performed 10,215 Medicare services across 1,706 unique beneficiaries.
Between the years covered by Open Payments, Dr. Khalil received a total of $15,077 from 80 pharmaceutical and/or device companies across 748 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in sports medicine (neuromusculoskeletal medicine) physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khalil is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice▲ Top 14% volume in TX$ $15,077 industry payments
Medicare Practice Summary
Medicare Utilization ↗10,215
Medicare services
Top 14% in TX for sports medicine (neuromusculoskeletal medicine) physician
1,706
Unique beneficiaries
$39
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~730 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) | 1,969 | $0 | $1 |
| MRI contrast dye injection (gadoterate) | 1,290 | $0 | $1 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 1,087 | $21 | $87 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 858 | $15 | $62 |
| Needle measurement of electrical activity in arm or leg muscles, complete study | 690 | $73 | $294 |
| Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 610 | $1 | $5 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 498 | $47 | $193 |
| Immune globulin infusion (Octagam) | 473 | $21 | $83 |
| Injection, diphenhydramine hcl, up to 50 mg | 345 | $1 | $3 |
| Unclassified drugs | 334 | $1 | $5 |
| Office visit, established patient (20-29 min) | 314 | $68 | $272 |
| Ultrasonic guidance for needle placement | 258 | $44 | $176 |
| Destruction of peripheral nerve or branch | 231 | $270 | $747 |
| Office visit, established patient (30-39 min) | 217 | $94 | $385 |
| Nerve conduction, 13 or more studies | 166 | $212 | $860 |
| New patient office visit, complex (60-74 min) | 161 | $155 | $664 |
| EEG, extended monitoring | 156 | $326 | $1,332 |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 96 | $0 | $1 |
| Measurement of brain wave activity (eeg), digital analysis | 66 | $202 | $831 |
| Blood draw (venipuncture) | 63 | $8 | $26 |
| Office visit, established patient (10-19 min) | 46 | $39 | $171 |
| Injection of carpal tunnel | 42 | $67 | $251 |
| Mri scan of brain before and after contrast | 41 | $247 | $1,006 |
| Injection of trigger points, 3 or more muscles | 37 | $40 | $186 |
| Office visit, established patient, complex (40-54 min) | 33 | $133 | $540 |
| Evaluation of brain response to sound for determination of hearing threshold with interpretation and report | 23 | $80 | $343 |
| Measurement of nerve conduction using visual stimulation testing with report | 21 | $48 | $200 |
| Nerve conduction, 9-10 studies | 18 | $162 | $638 |
| Study of facial nerve function | 16 | $55 | $214 |
| Measurement of nerve conduction patterns of eye blink reflex | 16 | $63 | $249 |
| Nerve conduction, 7-8 studies | 14 | $135 | $529 |
| Mri scan of blood vessels of head without contrast | 13 | $166 | $679 |
| Mri scan of lower spinal canal before and after contrast | 13 | $269 | $1,010 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
29.5% high complexity
44.9% medium
25.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$15,077
Total received (2018-2024)
Avg $2,154/year across 7 years
Top 0% in TX for sports medicine (neuromusculoskeletal medicine) physician
80
Companies
748
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,641 (97.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$437 (2.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,378
2023$2,940
2022$2,677
2021$1,688
2020$1,196
2019$1,435
2018$1,764
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,258
UCB, Inc.
$951
ABBVIE INC.
$926
SK Life Science, Inc.
$775
Teva Pharmaceuticals USA, Inc.
$678
Grifols USA, LLC
$611
Alexion Pharmaceuticals, Inc.
$591
Lundbeck LLC
$571
GENZYME CORPORATION
$564
PFIZER INC.
$522
Allergan, Inc.
$474
Takeda Pharmaceuticals U.S.A., Inc.
$427
JAZZ PHARMACEUTICALS INC.
$426
Biogen, Inc.
$370
ARGENX US, INC.
$350
Amgen Inc.
$330
Eisai Inc.
$294
Neurocrine Biosciences, Inc.
$268
Biohaven Pharmaceutical Holding Company Ltd.
$268
ACADIA Pharmaceuticals Inc
$249
Kerecis Limited
$222
Biohaven Pharmaceuticals, Inc.
$194
Lilly USA, LLC
$191
W. L. Gore & Associates, Inc.
$182
Kyowa Kirin, Inc.
$163
Mallinckrodt Hospital Products Inc.
$151
AQUESTIVE THERAPEUTICS, INC.
$150
Genentech USA, Inc.
$140
Janssen Pharmaceuticals, Inc
$118
Assertio Therapeutics, Inc.
$112
AbbVie Inc.
$111
HOSPIRA, INC.
$108
CSL Behring
$104
Acorda Therapeutics, Inc
$100
Vertical Pharmaceuticals, LLC
$93
Supernus Pharmaceuticals, Inc.
$92
Sunovion Pharmaceuticals Inc.
$86
Octapharma USA, Inc.
$85
Abbott Laboratories
$84
US WorldMeds, LLC
$83
EISAI INC.
$83
Promius Pharma LLC
$83
Allergan Inc.
$82
ARBOR PHARMACEUTICALS, INC.
$82
GlaxoSmithKline, LLC.
$81
Corium, LLC
$81
Avion Pharmaceuticals
$77
Sumitomo Pharma America, Inc.
$71
Boston Scientific Corporation
$69
EMD Serono, Inc.
$54
Strongbridge US INC.
$52
ASSERTIO THERAPEUTICS, Inc.
$47
CATALYST PHARMACEUTICALS, INC.
$47
LivaNova USA, Inc.
$45
Ipsen Biopharmaceuticals, Inc
$43
Otsuka America Pharmaceutical, Inc.
$42
GE HEALTHCARE
$40
Arbor Pharmaceuticals, Inc.
$38
Banner Life Sciences, LLC
$33
Aucta Pharmaceuticals, Inc.
$32
Amarin Pharma Inc.
$31
MITSUBISHI TANABE PHARMA AMERICA, INC.
$29
Azurity Pharmaceuticals, Inc.
$29
Musculoskeletal Transplant Foundation Inc.
$29
Currax Pharmaceuticals LLC
$28
BOSTON SCIENTIFIC CORPORATION
$27
Almatica Pharma LLC
$26
SpringWorks Therapeutics, Inc.
$25
Endo Pharmaceuticals Inc.
$24
Upsher-Smith Laboratories LLC
$23
UPSHER-SMITH LABORATORIES LLC
$19
Zyla Life Sciences
$19
Novo Nordisk Inc
$17
Amneal Pharmaceuticals LLC
$16
Horizon Pharma plc
$16
Scilex Pharmaceuticals Inc.
$14
SCILEX PHARMACEUTICALS INC.
$14
AstraZeneca Pharmaceuticals LP
$14
Avanir Pharmaceuticals, Inc.
$14
United Therapeutics Corporation
$13
Top 3 companies account for 20.8% of total payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRILINTA · Briviact · CAMBIA · CONTRAVE · COPAXONE · Cambia · Circulatory Support · DISEASE STATE · DIVIGEL · DUEXIS · Dhivy · Dysport · EMGALITY · EPIDIOLEX · ERBITUX · Edarbyclor · Esbriet · FYCOMPA · Fintepla · Fycompa · GAMMAGARD · GILENYA · GORE CARDIOFORM Septal Occluder · GRALISE · Gamunex-C · HORIZANT · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KEVEYIS · Kerecis Omega3 SurgiClose · LEMTRADA · LYRICA · Leqembi · MAVENCLAD · MAYZENT · Motpoly XR · NAPRELAN · NASCOBAL · NONE · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONZETRA XSAIL · OSMOLEX ER · Ocrevus · PANZYGA · Proclaim Family of SCS IPGs · Prolia · QULIPTA · RADICAVA · REXULTI · RYTARY · Repatha · Rystiggo · SOLIRIS · SOMATULINE DEPOT · SPINRAZA · SPRIX · SYMPAZAN · Saxenda · Soliris · TECFIDERA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TYSABRI · UBRELVY · ULTOMIRIS · VERCISE · VIGADRONE · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VYEPTI · VYVGART · VYVGART HYTRULO · Vascepa · Vercise · Vimpat · XARELTO · XCOPRI · Xadago · Xembify · ZEMBRACE SYMTOUCH · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 0% for sports medicine (neuromusculoskeletal medicine) physician in TX.
Equivalent to $148 per 100 Medicare services performed
Geographic Context
Sports Medicine (Neuromusculoskeletal Medicine) Physicians within 10 mi
3
Per 100K population
0.1
County median income
$73,104
Nearest hospital
HCA HOUSTON HEALTHCARE CLEAR LAKE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Khalil is a mixed practice specialist, with above-average Medicare volume (top 14% in TX), and high industry engagement (low-engagement, top 0%).
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Khalil experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Khalil performed 1,969 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khalil receive payments from pharmaceutical companies?
Yes. Dr. Khalil received a total of $15,077 from 80 companies across 748 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khalil's costs compare to other sports medicine (neuromusculoskeletal medicine) physicians in Webster?
Dr. Khalil's average Medicare payment per service is $39. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khalil) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Sports Medicine (Neuromusculoskeletal Medicine) Physicians in Webster
Browse sports medicine (neuromusculoskeletal medicine) physicians in Webster ranked by procedure volume and transparency data.
Highest volume
Top Sports Medicine (Neuromusculoskeletal Medicine) Physicians in TX
Sports Medicine (Neuromusculoskeletal Medicine) Physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Sports Medicine (Neuromusculoskeletal Medicine) Physicians in TX
Which TX sports medicine (neuromusculoskeletal medicine) physicians receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc..
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology